Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pascal Soriot
Fierce Pharma
AZ reveals plan for huge site in Virginia, part of $50B US outlay
AstraZeneca has unveiled a plan to invest $50 billion in the U.S. by 2030, including a multibillion dollar manufacturing facility in Virginia.
Kevin Dunleavy
Jul 22, 2025 7:45am
AstraZeneca CEO defends 'fantastic' Alexion buy as halts drug
Feb 6, 2025 6:45am
AZ eyes China's explosion of innovation for cell therapy
May 21, 2024 8:27am
AstraZeneca COVID-19 vaccine data hint at single-dose efficacy
Dec 9, 2020 7:40am
AstraZeneca nears temporary OK for COVID-19 vaccine
Nov 30, 2020 4:46am
AstraZeneca COVID-19 vaccine on track for 2020 filing: Soriot
Sep 10, 2020 8:25am
